HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Final Conviction In US FDA's Spiked-Supplement Investigation Of Blackstone Labs

Executive Summary

James Boccuzzi was the last person sentenced in connection with FDA's investigation of sports supplement firm Blackstone Labs for selling steroid-containing supplements after it ignored agency's warning to stop.

You may also be interested in...



US Wellness Market People News: RedCon1 ‘Prime Time,’ Mayweather Investment Offer, G Fuel, GAT

Deion Sanders invests in RedCon1, helps with product design; Mayweather needs investors in fitness projects; ‘Excellent Adventure’ and limited flavor in G Fuel box; and GAT Sport collaborates with Jeremy Buendia.

California ‘SARMs’ Business Doesn’t Fool FDA Stating ‘Research Only’ On Supplement Labels

In addition to SARMs-containing supplements, agency officials found on Warrior Labz SARMs’ website products offered for sale containing drugs indicated for erectile dysfunction. Product labeling states, “By purchasing from Warrior Labz SARMS you agree that you are purchasing Research Chemicals.”

US DoJ Has Own Eyes On Consumer Health Fraud

Firms moving from noncompliance to compliance with FDA or FTC requirements still could hear from federal prosecutors. “Our office has grown to the point that we generate a fair amount of work ourselves,” says Patrick Runkle, a trial attorney in DoJ Consumer Protection Branch.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152309

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel